SHC
Sotera Health Company
Diagnostics & Research · Healthcare · United States
18.70
close · 2026-10-29
value
80
cheaper than peers80
quality
57
stronger fundamentals57
ranked against
Diagnostics & Research
value
quality
31 peers
Value inputs
| measure | company | vs peers |
| forward P/E | 17.40× | 98 |
| EV to EBITDA | 12.65× | 97 |
| price to sales | 4.45× | 53 |
| price to book | 8.02× | 36 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 38.0% | 98 |
| return on equity | 27.8% | 84 |
| revenue growth | 9.2% | 37 |
| debt to equity | 340.7% | 2 |
4 of 4 measures available
Facts
| market cap | $5B |
| free cash flow | $154.0M |
| employees | 3,000 |
| first trade | 2020-11-20 |
| next earnings | 2026-11-03 |
| fundamentals updated | 2026-08-10 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | 0.27 | 0.16 | 0.18 | -0.83 |
| free cash flow | $149.2M | $45.1M | -$362.7M | $95.6M |
| net income | $77.9M | $44.4M | $51.4M | -$233.6M |
| revenue | $1.16B | $1.10B | $1.05B | $1.00B |
| unusual items | -$67.4M | -$24.4M | -$35.2M | -$417.8M |